Research Funded To Date
The Ben and Catherine Ivy Foundation is dedicated to finding a cure for brain cancer. We strive in improve the quality of life and increase the life expectancy of those diagnosed with brain cancer by funding promising research that creates more diagnostics and treatments for patients.
Since 2008, we have funded 33 separate institutions with over 107 different research grants totaling over $150 million. These grants have involved research in phase 0 clinical trials, biomarkers, genomics, imaging, immunotherapy, stem cell, vaccines, and the development of possible new drugs.
2014
NEUROLOGICAL SCIENCES INTERNSHIP PROGRAM AT TGEN DESIGNED TO GIVE HIGH SCHOOL AND UNDERGRADUATE STUDENTS INTENSIVE, HANDS-ON RESEARCH EXPERIENCE WORKING ALONGSIDE A MENTOR-SCIENTIST TO LEARN ABOUT TRANSLATIONAL RESEARCH WHILE INVESTIGATING QUESTIONS WITHIN THE NEUROLOGICAL SCIENCES.
PI: Brandy Wells
Director, Public Affairs and Education
Translational Genomics Research Institute (TGen)
IMAGING PHENOTYPES IN NEWLY DIAGNOSED GLIOBLASTOMA PROJECT TO EMPLOY THE UNIQUE IMAGING ARCHIVE THAT HAS BEEN COLLECTED BY MEMBERS OF THE IVY CONSORTIUM IN ORDER TO LINK PREVIOUSLY IDENTIFIED IMAGING METRICS TO OUTCOME (PROGRESSION-FREE AND OVERALL SURVIVAL) AND TO EXPLORE THE RELATIONSHIPS BETWEEN IN VIVO PARAMETERS AND MOLECULAR PROPERTIES OF CORRESPONDING TISSUE SAMPLES FROM THE VIRTUAL TUMOR BANK.
PI: Michael D. Prados, M.D.
Charles B. Wilson Professor of Neurosurgergery
Professor of Pediatrics (Neuro-Oncology)
Program Leader, Neurological Oncology Program, UCSF Helen Diller Cancer Center
Project Leader, Ivy Foundation Early Phase Clinical Trials Consortium
Project Leader, Pacific Pediatric Neuro-Oncology Consortium
University of California San Francisco (UCSF)
CREATION OF A RADIOGENOMICS PROJECT THAT WILL REPRESENT THE LARGEST SYSTEMATIC CORRELATION OF PRE/POST-OP IMAGING FEATURES WITH SPECIFIC GENOMIC MUTATIONS AND CLINICAL OUTCOME IN GLIOBLASTOMA.
PI: Michael D. Prados, M.D.
Charles B. Wilson Professor of Neurosurgergery
Professor of Pediatrics (Neuro-Oncology)
Program Leader, Neurological Oncology Program, UCSF Helen Diller Cancer Center
Project Leader, Ivy Foundation Early Phase Clinical Trials Consortium
Project Leader, Pacific Pediatric Neuro-Oncology Consortium
University of California San Francisco (UCSF)
INVESTIGATION OF THE SAFETY AND EFFICACY OF USING TARGETED RADIOTHERAPY TO ELIMINATE A HUMAN NEURAL STEM CELL NICHE THAT IS CO-OPTED BY GLIOBLASTOMA CELLS IN NEWLY-DIAGNOSED PATIENTS.
PI: Nader Sanai, M.D.
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological Institute